Chronic lymphocytic leukemia (CLL) is a hematological malignancy characterized by accumulation of CD19+/CD5+ cells resistant to apoptosis due to genetic lesions and microenvironment stimuli [1–3]. This evidence concerns the gene CD19 and B-cell chronic lymphocytic leukemia.